We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.


Download Mobile App
Recent News COVID-19 AI Critical Care Surgical Techniques Women's Health Patient Care Health IT Business

Perry Health

Reprocessed Urologic Endoscopes Harbor Infection Risk

By HospiMedica International staff writers
Posted on 12 Apr 2021
The US Food and Drug Administration (FDA; Silver Spring, MD, USA) has issued a warning on the risk for potentially life-threatening infections associated with reprocessed endoscopes used for viewing the urinary tract, including cystoscopes, cystouerthroscopes, and ureteroscopes. The warning comes after submission of more than 450 reports by manufacturers relating post-procedure infections and other possible contamination problems associated with the cleaning and sterilization of the devices.

Among these, Olympus (Tokyo, Japan) submitted three reports of deaths attributed to a bacterial infection. In two of these, the infection was linked to a forceps/irrigation plug, an accessory component used to control water flow and enable access to the working channel of the endoscope. The third victim's death involved a cystoscope that did not pass a leak test. According to the FDA, while not officially confirmed, it is possible that the damaged devices were a factor in the patients’ becoming infected.

Image: Inadequate reprocessing of urological endoscopes can have severe consequences (Photo courtesy of Getty Images)
Image: Inadequate reprocessing of urological endoscopes can have severe consequences (Photo courtesy of Getty Images)

“We are very concerned about the three reported deaths--outside of the United States--associated with these infections, and we’re acting fast to communicate with health care providers and the public about what we know and what is still an emerging issue,” said Jeff Shuren, MD, JD, director of FDA’s Center for Devices and Radiological Health. “While some reports indicate the potential causes could be inadequate reprocessing or device maintenance issues, we’re also evaluating other possibilities, including device design or the reprocessing instructions in the labeling.”

“Although we believe that the risk of infection is low based on available data, we’re reminding health care providers how important it is to follow the labeling and reprocessing instructions to properly clean and reprocess the devices, including accessory components,” concluded Dr. Shuren. “We take all reports of adverse events seriously, and we encourage prompt reporting to the FDA to help us identify and better understand the risks associated with reprocessed medical devices.”

Inadequate reprocessing of endoscopic devices between patients can result in the retention of blood, tissue, and other biological debris, which can allow microbes to survive the disinfection or sterilization process. Inadequate reprocessing can also result in other adverse patient outcomes, such as tissue irritation from residual chemical disinfectants.

Related Links:
US Food and Drug Administration

Latest Critical Care News